Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. S-1/A Offering Registration Statement
  2. 8-A12B Other Registration of Securities
  3. UPLOAD Other SEC-generated Letter
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1 Offering Registration Statement
  9. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  10. DRSLTR Other Correspondence Related to Draft Registration Statement
  11. DRS/A Other Draft Registration Statement
  12. UPLOAD Other SEC-generated Letter
  13. DRS/A Other Draft Registration Statement
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. DRSLTR Other Correspondence Related to Draft Registration Statement
  17. DRS/A Other Draft Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRSLTR Other Correspondence Related to Draft Registration Statement
  20. DRS/A Other Draft Registration Statement

Page 18 of 19 · 362 filings